Join the Class Action Against MacroGenics, Inc.
Levi & Korsinsky, LLP is reaching out to investors of MacroGenics, Inc. (NASDAQ: MGNX) regarding an important class action securities lawsuit. This lawsuit aims to help recover losses for those who have been negatively impacted by alleged securities fraud. The class period for this action runs from March 7, 2024, to May 9, 2024.
Understanding the Class Action Lawsuit
This lawsuit is specifically aimed at investors who incurred losses while investing in MacroGenics during the defined period. The central issue revolves around misleading statements concerning safety data from the company's TAMARACK Phase 2 study on vobramitamab duocarmazine. Following the revelations about the drug's risks, MGNX's stock saw a drastic decline of 77.4%, resulting in a loss of $11.36 per share.
What Investors Need to Know
Filing for Lead Plaintiff Status
If you faced a loss in MacroGenics stocks during this period, you have until September 24, 2024, to apply for lead plaintiff status. It’s important to note that you do not need to be a lead plaintiff to participate in any recovery from the lawsuit.
No Financial Risk
Joining the class action involves no financial risk for investors. If you are recognized as a class member, you may be eligible for compensation without having to pay any upfront fees or costs. This presents a valuable opportunity for investors looking to recover their losses.
Why Choose Levi & Korsinsky?
With over 20 years of experience, Levi & Korsinsky has successfully recovered hundreds of millions of dollars for dissatisfied shareholders throughout the United States. Their team is well-prepared to handle complex securities litigation, featuring over 70 dedicated professionals committed to assisting clients during difficult times. For seven consecutive years, they have been acknowledged as one of the leading firms in securities litigation by ISS Securities Class Action Services.
Investor Outreach Details
If you are an investor seeking additional information, please contact Joseph E. Levi, Esq. at (212) 363-7500. You are also welcome to reach out for further guidance regarding your options and the potential benefits of participating in this class action.
Frequently Asked Questions
What is the deadline to join the class action against MacroGenics?
The deadline for investors to join the class action is September 24, 2024.
Who can join the class action lawsuit?
Any investor who experienced losses during the class period from March 7, 2024, to May 9, 2024, is eligible to join the lawsuit.
Are there any fees to participate?
No, class members may be entitled to compensation without incurring any out-of-pocket costs or fees.
What does it mean to be a lead plaintiff?
Being a lead plaintiff means you would represent the class in the lawsuit, but it is not necessary to take on this role to benefit from potential recoveries.
Why is Levi & Korsinsky a good choice for representation?
Levi & Korsinsky has a strong history of recovering significant amounts for investors and is recognized as one of the top firms in securities litigation.